Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant

• Váldodahkkit: Gabiria Pastore (Dahkki), Jacopo Polvere (Dahkki), Fabio Fiorino (Dahkki), Simone Lucchesi (Dahkki), Giorgio Montesi (Dahkki), Ilaria Rancan (Dahkki), Sara Zirpoli (Dahkki), Arianna Lippi (Dahkki), Miriam Durante (Dahkki), Massimiliano Fabbiani (Dahkki), Mario Tumbarello (Dahkki), Francesca Montagnani (Dahkki), Donata Medaglini (Dahkki), Annalisa Ciabattini (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

ABSTRACTBackground Heterologous prime-boost schedules have been employed in SARS-CoV-2 vaccination, yet additional data on immunogenicity and effectiveness are still needed.Research design and methods Here, we measured the immunogenicity and effectiveness in the real-world setting of the mRNA booste...